Results 291 to 300 of about 89,882 (308)

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Signal Transduction and Targeted Therapy, 2020
Xunbin Wei, Shengyu Yang, Jihui Hao
exaly  

Pancreatic Ductal Carcinoma

2018
openaire   +1 more source

Pancreatic Ductal Carcinoma

2015
openaire   +1 more source

[Pancreatic carcinoma (ductal adenocarcinoma)].

Praxis, 2006
U, Kolyvanos Naumann, L, Käser, W, Vetter   +2 more
openaire   +1 more source

Cancer statistics: Breast cancer in situ

Ca-A Cancer Journal for Clinicians, 2015
Otis W Brawley
exaly  

Dilemma of pancreatic ductal carcinoma.

The American journal of gastroenterology, 1979
L, Weingarten, A M, Gelb, M G, Fischer
openaire   +1 more source

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Nature Reviews Cancer, 2010
Sam C Wang, Matthias Hebrok
exaly  

Acinar cell plasticity and development of pancreatic ductal adenocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2017
Peter Storz
exaly  

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

Cancer Cell, 2012
Paolo P Provenzano, Sunil R Hingorani
exaly  

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Cancer Cell, 2005
Sunil R Hingorani, Lifu Wang, Ralph H Hruban   +2 more
exaly